2021, Number 6
Hyperglycemia and leukocytosis as predictive factors of in-hospital complications in patients with Acute myocardial infarction
Language: Spanish
References: 26
Page: 1-7
PDF size: 604.56 Kb.
ABSTRACT
Introduction: Despite the use of novel techniques for reperfusion of the vessel in acute myocardial infarction, complications and mortality in these patients are high. Hyperglycemia and leukocytosis have been described as risk factors and worse prognosis.Objective: To evaluate the predictive capacity of hyperglycemia and leukocytosis for in-hospital complications of myocardial infarction with ST-segment elevation patients.
Material and Methods: Prospective cohort study conducted from 2013 to 2020 that included 507 consecutive patients admitted to the Intensive Coronary Care Unit of the “Dr. Carlos J. Finlay” Central Military Hospital and the “Enrique Cabrera” General Teaching Hospital with the diagnosis of acute myocardial infarction with ST- segment elevation. The patients were divided into groups according to the occurrence of in-hospital complications.
Results: The values of glycemia and leukocyteswere significantly different among the groups of patients (p = 0.002 and p = 0.005; respectively). The discriminative capability of both tests was classified as bad. The univariate analysis of logistic regression revealed that glycemia and leukocytes were risk factors for the appearance of complications, but only the leukocyte test was considered as an independent predictor of the final event of the study. When the values of the leukocyte test were associated with the multivariate model, its predictive capacity increased (area under curve: 0.735; p < 0.001).
Conclusions: Leukocytosis is an independent predictor of in-hospital complications of acute myocardial infarction with ST-segment elevation.
REFERENCES
Bajpai G, Bredemeyer A, Li W, Zaitsev K, Koening AL, Lokshina I, et al. Tissue resident CCR2− and CCR2+ cardiacmacrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury.Circulation Research [Internet]. 2019;124(2):263-78. Disponible en: https://doi.org/10.1161/CIRCRESAHA.118.314028
Mi Sh, Su G, Yang H, Zhou Y, Tian L, Zhang T, et al. Comparison of in-hospital glycemic variability and admission bloodglucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwentpercutaneous coronary intervention. Diabetol Metab Syndr [Internet]. 2017;9:[Aprox. 8 p.]. Disponible en: https://doi.org/10.1186/s13098-017-0217-1
Pesaro AEP, Nicolau JC, Serrano CV, Truffa R, Gaz MVB, Karbstein R, et al. Influencia de Leucocitos y Glucemia en elPronóstico de Pacientes con Infarto Agudo de Miocardio. Arq Bras Cardiol [Internet]. 2009 [Citado 09/07/2021];92(2):84-9. Disponible en: https://www.scielo.br/j/abc/a/QHcPzmWnNb5vqTLHvY5TzpQ/abstract/?lang=es
ChacónDíaz M, Vega A, Araoz O, Ríos P, Baltodano R, Villanueva F, et al. Características epidemiológicas del infartode miocardio con elevación del segmento ST en Perú: resultados del P Eruvian Registry of ST-segment ElevationMyocardial Infarction (PERSTEMI). Arch Cardiol Mex [Internet]. 2018 [Citado 23/08/2021];88(5):403-12. Disponibleen: http://www.scielo.org.mx/pdf/acm/v88n5/1665-1731-acm-88-05-403.pdf
García Aurelio MJ, Cohen Arazi H, Higa C, Gómez HR, Mauro V, Fernández H, et al. Infarto agudo de miocardiocon supradesnivel persistente del segmento ST. Registro multicéntrico SCAR (Síndromes Coronarios Agudos enArgentina) de la Sociedad Argentina de Cardiología. Rev Argent Cardiol [Internet]. 2014 [Citado 14/07/2021];82:275-84. Disponible:http://www.old2.sac.org.ar/wp-content/uploads/2014/08/v82n4a04-es.pdf
Gagliardi JA, Charask A, Perna E, D´Imperio H, Bono H, Castillo Y, et al. Encuesta nacional de infarto agudode miocardio con elevación del ST en la República Argentina (ARGEN-IAM-ST). Rev Argent Cardiol [Internet].2016 [Citado 12/07/2021];84:548-57. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1850-37482016000600006
Hoedemaker NPG, ten Haaf ME, Maas JC, Damman P, Appelman Y, Tijssen JGP, et al. Practice of ST-segmentelevation myocardial infarction care in the Netherlands during four snapshot weeks with the National CardiovascularDatabase Registry for Acute Coronary Syndrome. Neth Heart J [Internet]. 2017;25:264-70. Disponible en: http://doi.org/10.1007/s12471-017-0947-6
Melo de Barros PGS, Berwanger O, Silva ES, Sobral ACS, Assad MC, Beraldo PA, et al. Avaliação do Seguimento deum Ano dos Pacientes Incluídos no Registro Brasileiro de Síndromes Coronárias Agudas (ACCEPT). Arq Bras Cardiol[Internet]. 2020;114(6):995-1003. Disponible en: https://doi.org/10.36660/abc.20190879
García García C, Oliveras T, Serra J, Vila J, Rueda F, Cediel G, et al. Trends in Short- and Long-Term ST-Segment–Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population-Based ST-Segment–ElevationMyocardial Infarction Registry. J Am Heart Assoc [Internet]. 2020;9:e017159. Disponible en: http://doi.org/10.1161/JAHA.120.017159
Alhabib KF, Kinsara AJ, Alghamdi S, Al Murayeh M, Hussein GA, Al Saif S, et al. The first survey of the Saudi AcuteMyocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program). PLoS ONE [Internet].2019;14(5):e0216551. Disponible en: https://doi.org/10.1371/journal.pone.0216551
Santos MM, Rodríguez MR, Prohias JM, Mata LAC, Martínez GG, Sellen ES, et al. Registro Cubano de Infarto de MiocardioAgudo (RECUIMA), los primeros 1000 casos. Rev Cub Cardiol Cir Cardiovasc [Internet]. 2019 [Citado 21/08/2021];25(3Suppl 1):419-35. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/895
Hong D, Hong KC, Bin YS, Myung JL, Kyu TP, Hoon JY, et al. Prognostic implications of post-percutaneous coronaryintervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction.Scien Rep [Internet]. 2019;9(1):9646 [Aprox. 9 p.]. Disponible en: https://doi.org/10.1038/s41598-019-46117-8
Akhtar N, Adil MM, Ahmed W, Habib-ur-Rehman, Shahs MA. The role of leukocyte counts in patients with unstableangina pectoris or myocardial infarction: prognostic significance and correlation with plasma brain natriuretic peptide(BNP) levels. J Pak Med Assoc [Internet]. 2011 Jan [Citado 14/05/2021];61(1):51-4. Disponible en:https://pubmed.ncbi.nlm.nih.gov/22368903/
Gomez Arbelaez D, Sánchez Vallejo G, Perez M, Garcia RG, Freddy JA, Peñaherrera E, et al. Hiperglucemia se asociaa mayor número de desenlaces adversos en individuos latinoamericanos con infarto agudo de miocardio. Clin InvestigArterioscl [Internet]. 2016;28(1):9-18. Disponible en: http://dx.doi.org/10.1016/j.arteri.2015.09.003
Issa M, Alqahtani F, Berzingi C, AlHajji M, Busu T, Alkhouli M. Impact of acute diabetes decompensation on outcomesof diabetic patients admitted with ST-elevation myocardial infarction. Diabetol Metab Syndr [Internet]. 2018 [Citado17/06/2021];10:[Aprox. 8p.]. Disponible en: https://doi.org/10.1186/s13098-018-0357-y
Kalińczuk Ł, Zieliński K, Pręgowski J, Przyłuski J, Karcz M, Bekta P, et al. Higher admission glycaemia independentlyof diagnosed or unrecognized diabetes mellitus is a risk factor for failed myocardial tissue reperfusion and highermortality after primary angioplasty. Kardiologia Polska [Internet]. 2018 [Citado21/07/2021];76(3):594-601. Disponibleen: www.kardiologiapolska.pl
Karetnikova V, Gruzdeva O, Uchasova E, Osokina A, Barbarash O. Glucose levels as a prognostic marker in patientswith ST-segment elevation myocardial infarction: a case–control study. BMC Endocrine Disorders [Internet]. 2016[Citado 21/07/2021];16(1):31. Disponible en: https://doi.org/10.1186/s12902-016-0108-8